E-LIB Suche - Ergebnisse für: Berrin Balık Aydın

1

Germline CEBPA Mutation as a Rare Cause of Chronic Neutrope..:

Askin, Abdullah Emre ; Bektas, Sebnem ; Serin, Istemi...
Indian Journal of Hematology and Blood Transfusion. 40 (2024) 3 - p. 527-530 , 2024

Link: https://doi.org/10.1007/..

2

Pegaspargase, venetoclax, and nelarabine: a successful brid..:

Yiğit Kaya, Süreyya ; Bektas, Sebnem ; Askin, Abdullah Emre...
Annals of Hematology. 102 (2023) 6 - p. 1599-1600 , 2023

Link: https://doi.org/10.1007/..

3

POSTER: CT-151 A Rare Bleeding Diathesis With Subacute Sple..:

Aydın, Berrin Balık
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S234 , 2023

Link: https://doi.org/10.1016/..

4

CT-151 A Rare Bleeding Diathesis With Subacute Splenic Hema..:

Aydın, Berrin Balık
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S519-S520 , 2023

Link: https://doi.org/10.1016/..

5

CYTARABİNE-İNDUCED NEUROTOXİCİTY WELL-RESPONDİNG TO METHYL ..:

Aydin, Berrin Balik
Hematology, Transfusion and Cell Therapy. 45 (2023) - p. S31 , 2023

Link: https://doi.org/10.1016/..

6

Plerixafor in autologous stem cell transplantation: Does it..:

Serin, Istemi ; Sevindik, Omur Gokmen ; Balik Aydin, Berrin...
Transfusion and Apheresis Science. 62 (2023) 6 - p. 103809 , 2023

Link: https://doi.org/10.1016/..

7

CD5 as a prognostic marker in patients with diffuse large B..:

Demirci, Ufuk ; Kırkızlar, Hakkı Onur ; Ümit, Elif G....
Journal of Hematopathology. 15 (2022) 4 - p. 203-213 , 2022

Link: https://doi.org/10.1007/..

8

Prognostic Factors and Intensive Care Outcome in Post-Trans..:

Mutlu, Yaşa Gül ; Aydin, Berrin Balik ; Erdogan, Cem...
Indian Journal of Hematology and Blood Transfusion. 39 (2022) 2 - p. 167-172 , 2022

Link: https://doi.org/10.1007/..

9

To rechallenge or not to rechallenge, that is the question?..:

Sevindik, Omur Gokmen ; Mergen, Mahmut ; Mergen, Sena...
Annals of Hematology. 101 (2022) 11 - p. 2545-2547 , 2022

Link: https://doi.org/10.1007/..

10

First-line Usage of Daratumumab, Lenalidomide, Dexamethason..:

Sevindik, Omur Gokmen ; Mutlu, Yasa Gul ; Aydin, Berrin Balik.
HemaSphere. 6 (2022) 7 - p. e728 , 2022

Link: https://doi.org/10.1097/..

11

Clinical Characteristics and Outcomes of COVID-19 in Turkis..:

Civriz Bozdağ, Sinem ; Seval, Güldane Cengiz ; Yönal Hindilerden, İpek...
Turkish Journal of Hematology. 39 (2022) 1 - p. 43-54 , 2022

Link: https://doi.org/10.4274/..

12

Persistent Polyclonal B-cell Lymphocytosis with Binucleated..:

Balık Aydın, Berrin ; Mutlu, Yaşa Gül ; Sevindik, Ömür Gökmen
Turkish Journal of Hematology. , 2021

Link: https://doi.org/10.4274/..

13

IBCL-386: Rituximab-Vemurafenib Combination for the Treatme..:

Sevindik, Ömür ; Gemici, Aliihsan ; Mutlu, Yasa Gul..
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) - p. S286 , 2020

Link: https://doi.org/10.1016/..

14

Should Core Needle Lymph Node Biopsy be a Relevant Alternat..:

Yaşa Gül Mutlu ; Berrin Balık Aydın ; Aslı Çakır...
https://www.eajm.org/en/should-core-needle-lymph-node-biopsy-be-a-relevant-alternative-to-surgical-excisional-biopsy-in-diagnostic-work-up-of-lymphomas-133482. , 2023

Link: https://doi.org/10.5152/..

15

CYTARABİNE-İNDUCED NEUROTOXİCİTY WELL-RESPONDİNG TO METHYL ..:

Berrin Balik Aydin
http://www.sciencedirect.com/science/article/pii/S2531137923002274. , 2023

Link: https://doi.org/10.1016/..